Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12611461 | Bioorthogonal compositions | 🖼🧊📄§ | 2026-04-28 | 2045-04-16 | 0 | 31 |
| 12611462 | Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2042-07-14 | 0 | 31 |
| 12612362 | Anisomycin derivative and use of anisomycin and derivative thereof as GLP-1R agonist | 🖼🧊📄§ | 2026-04-28 | 2043-07-24 | 0 | 31 |
| 12612427 | Aryl glucoside derivative, preparation method therefor and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-24 | 0 | 31 |
| 12612464 | Autoantibody specifically binding to NELL-1 and elevated NELL-1 polypeptide levels for identifying and treating membranous nephropathy | 🖼🧊📄§ | 2026-04-28 | 2040-09-18 | 0 | 31 |
| 12612392 | Compound, pharmaceutical compositions containing same, synthesis method therefor and use thereof | 🖼🧊📄§ | 2026-04-28 | 2045-07-07 | 0 | 31 |
| 12612409 | Pyrrolopyrimidines as CFTR potentiators | 🖼🧊📄§ | 2026-04-28 | 2043-04-13 | 0 | 31 |
| 12612364 | Salts and solid forms of 4-hydroxy-N,N-diisopropyltryptamine hemi-glutarate and hemi-succinate | 🖼🧊📄§ | 2026-04-28 | 2045-12-03 | 0 | 31 |
| 12612374 | Thiazole and diphenyl substituted sulfoxides for use in improving cognition functions and against addictions to substances | 🖼🧊📄§ | 2026-04-28 | 2040-09-10 | 0 | 31 |
| 12612453 | Method of treating glomerulonephritis by administering an antibody which binds and neutralizes human TGF-Beta1, TGF-Beta2 and TGF-Beta3 | 🖼🧊📄§ | 2026-04-28 | 2042-09-16 | 0 | 31 |
| 12612426 | Aryl glucoside derivative | 🖼🧊📄§ | 2026-04-28 | 2040-11-24 | 0 | 31 |
| 12612448 | Tumor-targeting A56 protein or fragment thereof, antibody binding to A56 protein, and use thereof | 🖼🧊📄§ | 2026-04-28 | 2040-10-05 | 0 | 31 |
| 12612443 | Cell | 🖼🧊📄§ | 2026-04-28 | 2041-11-12 | 0 | 31 |
| 12612354 | Cyclopentenones derivatives and their use as antibiotics | 🖼🧊📄§ | 2026-04-28 | 2041-12-09 | 0 | 31 |
| 12612365 | Compounds and methods for treating alcohol disorder | 🖼🧊📄§ | 2026-04-28 | 2041-11-30 | 0 | 31 |
| 12612385 | Compounds and methods for targeting pathogenic blood vessels | 🖼🧊📄§ | 2026-04-28 | 2043-11-27 | 0 | 31 |
| 12612369 | Eco-friendly synthesis of a novel nicotinonitrile derivative (MNPN) with antibacterial and anti-inflammatory activities for preventing pressure ulcers in individuals with disabilities | 🖼🧊📄§ | 2026-04-28 | 2045-12-15 | 0 | 31 |
| 12612395 | Rocaglate derivatives and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2044-10-02 | 0 | 31 |
| 12612410 | Multi-cyclic IRAK and FLT3 inhibiting compounds and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2041-12-23 | 0 | 31 |
| 12612417 | Deuterated analogues of selenophenochromenes, synthesis thereof, and methods of using same agents | 🖼🧊📄§ | 2026-04-28 | 2040-07-21 | 0 | 31 |
| 12612430 | Peptides | 🖼🧊📄§ | 2026-04-28 | 2040-09-11 | 0 | 31 |
| 12612447 | April and BAFF inhibitory immunomodulatory proteins and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2043-03-17 | 0 | 31 |
| 12612446 | CTLA-4 variant immunomodulatory proteins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2043-01-30 | 0 | 31 |
| 12612451 | Method of treating neuromyelitis optica spectrum disorder (NMOSD) comprising administering an anti-C5 antibody | 🖼🧊📄§ | 2026-04-28 | 2040-12-08 | 0 | 31 |
| 12612449 | HIV-1 antibodies | 🖼🧊📄§ | 2026-04-28 | 2041-06-10 | 0 | 31 |
| 12612456 | CD19 antibodies and methods of using the same | 🖼🧊📄§ | 2026-04-28 | 2040-04-07 | 0 | 31 |
| 12612459 | Methods of identifying agents that block MCD28 cleavage by MMPS | 🖼🧊📄§ | 2026-04-28 | 2040-12-02 | 0 | 31 |
| 12612467 | Treatment of necrotizing enterocolitis with semisynthetic polyclonal human secretory immunoglobin A | 🖼🧊📄§ | 2026-04-28 | 2042-09-21 | 0 | 31 |
| 12612439 | Mutant bacteriorhodopsin-like-channelrhodopsin ion channel | 🖼🧊📄§ | 2026-04-28 | 2043-02-03 | 0 | 31 |
| 12611399 | Movement disorders | 🖼🧊📄§ | 2026-04-28 | 2042-05-01 | 0 | 31 |
| 12611439 | Ionic self-assembling peptides | 🖼🧊📄§ | 2026-04-28 | 2043-02-09 | 0 | 31 |
| 12611409 | Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor | 🖼🧊📄§ | 2026-04-28 | 2042-03-15 | 0 | 31 |
| 12611423 | Medical use of tafoxiparin | 🖼🧊📄§ | 2026-04-28 | 2043-05-02 | 0 | 31 |
| 12612463 | Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors | 🖼🧊📄§ | 2026-04-28 | 2044-01-19 | 0 | 31 |
| 12612462 | Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding IL33 and IL1RL1 | 🖼🧊📄§ | 2026-04-28 | 2043-06-07 | 0 | 31 |
| 12612460 | Anti-PD-1 antibodies and fusion proteins | 🖼🧊📄§ | 2026-04-28 | 2044-12-20 | 0 | 31 |
| 12612424 | HPK1 inhibitors and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-07-03 | 0 | 31 |
| 12612389 | Benzofuran-based N-acylhydrazone derivative and pharmaceutical composition comprising same | 🖼🧊📄§ | 2026-04-28 | 2040-07-14 | 0 | 31 |
| 12612407 | Imidazo[2,1-f][1,2,4]triazin-4-amine derivatives as TLR7 agonist | 🖼🧊📄§ | 2026-04-28 | 2040-02-06 | 0 | 31 |
| 12612408 | Pyrazolone-fused pyrimidine compound, preparation method for same and applications thereof | 🖼🧊📄§ | 2026-04-28 | 2040-06-28 | 0 | 31 |
| 12611456 | Use of thiazole amide compounds for modulating human immune response | 🖼🧊📄§ | 2026-04-28 | 2040-09-16 | 0 | 31 |
| 12611460 | Eyedrop compositions | 🖼🧊📄§ | 2026-04-28 | 2039-09-18 | 0 | 31 |
| 12611379 | Lipid nano drug delivery system targeting brain lesion and preparation method and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-13 | 0 | 31 |
| 12611381 | Cationic hyaluronic acid coated spanlastics and preparation and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-04-02 | 0 | 31 |
| 12611400 | Solid lipid nano-composition containing berberine and cinnamonaldehyde effective in treating diabetes, dyslipidemia, and method of preparing the same | 🖼🧊📄§ | 2026-04-28 | 2040-12-04 | 0 | 31 |
| 12611428 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-04-28 | 2040-12-02 | 0 | 31 |
| 12611443 | Methods and compositions related to therapeutic peptides for cancer therapy | 🖼🧊📄§ | 2026-04-28 | 2041-06-14 | 0 | 31 |
| 12606558 | Condensed pyrazole derivatives as inhibitors of SARM1 | 🖼🧊📄§ | 2026-04-21 | 2041-04-07 | 0 | 31 |
| 12606566 | Substituted cyclopenta[4,5]pyrrolo[1,2-a]pyrazines as bruton's tyrosine kinase inhibitors | 🖼🧊📄§ | 2026-04-21 | 2041-06-18 | 0 | 31 |
| 12606594 | Heterotandem bicyclic peptide complexes | 🖼🧊📄§ | 2026-04-21 | 2042-02-02 | 0 | 31 |